Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-solid Organ Transplant”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Testing effectiveness (Phase 2)Study completedNCT00066469
What this trial is testing

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Who this might be right for
Lymphoproliferative Disorder
Children's Oncology Group 55
Not applicableNot Yet RecruitingNCT07592806
What this trial is testing

CRISTEL Study: Monitoring of Pregnancies in Women After Solid Organ Transplantation

Who this might be right for
Surgical Operation With Transplant of Whole Organ
Hopital Foch 2,000
Not applicableActive Not RecruitingNCT02991105
What this trial is testing

Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study

Who this might be right for
MalignancyTransplant ComplicationCancer+3 more
University of Birmingham 85,410
Early research (Phase 1)UnknownNCT02779439
What this trial is testing

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Who this might be right for
CMV InfectionEBVAdenovirus
University of Sydney 25
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Early research (Phase 1)Looking for participantsNCT06741072
What this trial is testing

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Who this might be right for
Chronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5EBV-Related Lymphoproliferative Disorder+2 more
Ohio State University Comprehensive Cancer Center 55
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Not applicableUnknownNCT00886158
What this trial is testing

Virus Surveillance in Pediatric Solid Organ Transplant Recipients

Who this might be right for
Viral Infections
Seattle Children's Hospital 100
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)Study completedNCT00064246
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

Who this might be right for
Post-transplant Lymphoproliferative DisorderRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+5 more
National Cancer Institute (NCI) 28
Not applicableStudy completedNCT06937463
What this trial is testing

Use of an Off-the-Shelf Exergame as an In-Bed Gamified Rehabilitation Intervention for Severely Deconditioned Inpatients: A Feasibility Study

Who this might be right for
Bed-ridden PatientSolid Organ TransplantPost Critical Care
Asan Medical Center 26
Not applicableWithdrawnNCT03327987
What this trial is testing

Early Flu Shots in SOT

Who this might be right for
InfluenzaSolid Organ Transplant
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT02042391
What this trial is testing

Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy

Who this might be right for
Posttransplant Lymphoproliferative Disorder
Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH 60
Large-scale testing (Phase 3)Ended earlyNCT05047640
What this trial is testing

COVID-19 3rd Dose Vaccine in Transplant Patients

Who this might be right for
Covid19
Giselle Guerra 58
Large-scale testing (Phase 3)Looking for participantsNCT03394365
What this trial is testing

Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Who this might be right for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament
Early research (Phase 1)Ended earlyNCT01841632
What this trial is testing

Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

Who this might be right for
Liver Transplantation
Prof. Dr. Marc-H. Dahlke, Ph. D. 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Not applicableStudy completedNCT05907434
What this trial is testing

Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Solid Organ Transplant

Who this might be right for
Acute Kidney Injury
Policlinico Hospital 160
Next Page
115
190